Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Methyl 5-(4-fluorophenylsulfonyloxy)benzimidazole-2-carbamate
1. 90509-02-7
2. Luxabendazolum
3. Hoe 216v
4. Methyl 5-hydroxy-2-benzimidazolecarbamate, P-fluorobenzenesulfonate (ester)
5. Hoe-216v
6. 34s1s00gv3
7. Luxabendazol
8. Luxabendazol [spanish]
9. Luxabendazolum [latin]
10. Ccris 7645
11. Luxabendazole [inn:ban]
12. Unii-34s1s00gv3
13. [2-(methoxycarbonylamino)-3h-benzimidazol-5-yl] 4-fluorobenzenesulfonate
14. Luxabendazole [inn]
15. Schembl321908
16. Chembl2104764
17. Dtxsid00238189
18. Methyl 5-(4-fluorophenylsulfonyloxy)benzimidazole-2-carbamate
19. 2-benzimidazolecarbamate, 5-hydroxy-, P-fluorobenzenesulfoonate
20. Zinc1842766
21. Akos015901189
22. Akos015967126
23. 509l027
24. Luxabendazole, Vetranal(tm), Analytical Standard
25. J-505262
26. Q27256388
27. 2-((methoxycarbonyl)amino)-1h-benzo[d]imidazol-5-yl 4-fluorobenzenesulfonate
28. Benzenesulfonic Acid, 4-fluoro-, 2-[(methoxycarbonyl)amino]-1h-benzimidazol-6-yl Ester
Molecular Weight | 365.3 g/mol |
---|---|
Molecular Formula | C15H12FN3O5S |
XLogP3 | 2.7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 5 |
Exact Mass | 365.04816983 g/mol |
Monoisotopic Mass | 365.04816983 g/mol |
Topological Polar Surface Area | 119 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 576 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?